CRVO · CervoMed Inc.
$2.60
-0.04 (-1.52%)
At close · Aug 28
Going-concern doubt
— cleared Aug 7, 2026
The latest filing no longer states the doubt (first flagged May 15, 2026).
View the 10-Q filed Aug 7, 2026Market Cap
$39.76M
Shares
15.12M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$4.01M
-58.9%
FY2025
Net Income
-$26.97M
-65.5%
FY2025
Gross Margin
100%
+63pp
FY2013
Operating Margin
-706.22%
-519pp
FY2025
Diluted EPS
$3,058,336.50
+4.7%
FY2022
Operating Cash Flow
-$23.45M
-41.9%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $331.3K | $4.01M | $9.74M | $7.14M | $0 | — | — | — | — | — | — | — | — | $71.67K | $374.54K | $570.48K | $40.19K | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | $0 | $235.8K | $2.31M | $210.39K | |
| $71.67K | — | — | — | — | — | — | — | — | — | — | — | — | $71.67K | $138.74K | -$1.74M | -$170.2K | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | 100% | 37.04% | -304.68% | -423.51% | |
| $21.33M | $21.82M | $18.8M | $8.44M | $1.34M | $8.5M | $9.43M | $6.62M | $5.75M | $5.09M | $7.25M | $3.88M | $2.86M | $342.92K | — | $0 | — | |
| $10.17M | $10.48M | $9.17M | $6.52M | $2.14M | $7.45M | $6.44M | $4.83M | $6.17M | $6.19M | $11.09M | $2.52M | $4.76M | $7.33M | $4.57M | $6.7M | $2.17M | |
| — | — | — | — | — | — | — | — | — | — | — | $0 | $554.34K | — | — | — | — | |
| — | — | — | — | $0 | $93.42K | $103.17K | — | — | — | — | $23.27K | $566.26K | $116.45K | $164.04K | $69.81K | $49.67K | |
| $31.5M | $32.3M | $27.97M | $14.96M | $3.48M | — | — | — | — | — | — | $23.83M | $14.61M | $12.8M | $11.93M | $14.69M | $7.47M | |
| -$31.16M | -$28.29M | -$18.23M | -$7.81M | -$3.48M | -$24.68M | -$15.97M | -$11.55M | -$18.96M | -$11.35M | -$18.37M | -$6.41M | -$14.61M | -$12.8M | -$11.79M | -$16.43M | -$7.64M | |
| — | -706.22% | -187.18% | -109.35% | — | — | — | — | — | — | — | — | — | -17855.55% | -3148.34% | -2879.94% | -19002.6% | |
| — | — | — | — | -$3.48M | -$24.58M | -$15.87M | — | — | — | — | -$6.38M | -$14.05M | -$12.68M | -$11.63M | -$16.36M | -$7.59M | |
| — | — | — | $0 | $587 | — | — | — | $3000 | $100K | $37K | $313.12K | $273.5K | $126.48K | -$167.89K | $30.54K | — | |
| $812.01K | $1.34M | $1.94M | $219.43K | $62.23K | — | — | — | — | — | — | — | — | — | — | — | — | |
| $815.05K | $1.33M | $1.94M | $5.64M | -$2.33M | — | — | — | — | — | — | $6357 | -$2.56M | $9.83M | -$4.94M | -$6.21M | -$772.65K | |
| — | — | — | — | -$15.59M | -$24.54M | -$15.86M | -$11.47M | -$18.81M | -$2.42M | -$18.4M | -$6.72M | -$17.17M | -$2.97M | — | — | — | |
| — | $0 | — | — | $0 | -$443.89K | -$1.68M | $332.89K | -$437.29K | -$1.06M | -$364.8K | $0 | -$2.82M | $0 | $0 | — | — | |
| -$30.35M | -$26.97M | -$16.29M | -$2.17M | -$5.8M | -$24.1M | -$14.19M | -$11.8M | -$18.37M | -$1.36M | -$18.04M | -$6.72M | -$14.35M | -$2.46M | -$6.87M | -$22.64M | -$8.41M | |
| — | -673.06% | -167.29% | -30.4% | — | — | — | — | — | — | — | — | — | -3429.68% | -1833.94% | -3967.89% | -20925.14% | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | $6401 | $19.08K | — | — | |
| — | — | — | — | — | -$24.1M | -$16.14M | -$11.8M | -$26.62M | -$2.62M | -$18.04M | -$23.82M | -$14.35M | -$2.64M | -$7.37M | -$23.03M | — | |
| -$30.35M | -$27.02M | -$16.23M | -$2.17M | -$15.63M | -$24.1M | — | — | — | — | — | — | — | — | — | — | — | |
| USD/shares | -$3.22 | -$2.98 | -$2.02 | -$0.82 | -$11.20 | -$18.57 | -$22.50 | -$132.00 | -$615.75 | -$237.00 | -$132.00 | — | — | — | — | — | — |
| USD/shares | — | — | — | — | $3,058,336.50 | $2,920,288.50 | $4,037,397,975.00 | $502,988,175.00 | $243,172,575.00 | -$2,183.25 | -$132.00 | — | — | — | — | — | — |
| shares | — | 9.04M | 8.07M | 2.66M | 518.14K | — | — | — | 43.23K | 11.03K | 136.44K | 248.2K | 190.66K | — | — | 1.01M | 769.24K |
| shares | — | — | — | — | — | — | — | — | 43.23K | 11.31K | 136.44K | 248.2K | 190.66K | 35.29K | 14.96K | 1.35M | 769.24K |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 4.72×
EV/EBIT
—
P/E (TTM)
—
Peer median 5.70×
Peer medians compare against the 270 similar-size Biotechnology companies (of 524 listed).
Key facts
CIK
1053691
CUSIP
15713L109
13F (30d)
36 filings
35 filers
Visit website
Investor relations